Legis Daily

To amend title XVIII of the Social Security Act to require prescription drug plan sponsors under the Medicare program to establish drug management programs for at-risk beneficiaries.

USA115th CongressHR-5675| House 
| Updated: 6/12/2018
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (6)
Ben Ray Luján (Democratic)Marsha Blackburn (Republican)Greg Walden (Republican)Peter J. Roskam (Republican)Sander M. Levin (Democratic)Bill Posey (Republican)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill requires Medicare prescription drug plan (PDP) sponsors, for plan years beginning on or after January 1, 2021, to establish drug management programs for at-risk beneficiaries. Current law authorizes, but does not require, PDP sponsors to establish such programs.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 3, 2018
Introduced in House
May 3, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 9, 2018
Committee Consideration and Mark-up Session Held.
May 9, 2018
Ordered to be Reported by Voice Vote.
May 16, 2018
Referred to the Subcommittee on Health.
Jun 12, 2018
Placed on the Union Calendar, Calendar No. 577.
Jun 12, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-743, Part I.
Jun 12, 2018
Committee on Ways and Means discharged.
  • May 3, 2018
    Introduced in House


  • May 3, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 9, 2018
    Committee Consideration and Mark-up Session Held.


  • May 9, 2018
    Ordered to be Reported by Voice Vote.


  • May 16, 2018
    Referred to the Subcommittee on Health.


  • June 12, 2018
    Placed on the Union Calendar, Calendar No. 577.


  • June 12, 2018
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-743, Part I.


  • June 12, 2018
    Committee on Ways and Means discharged.

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • HR 115-5773: PASS Act of 2018
Drug, alcohol, tobacco useMedicarePrescription drugs

To amend title XVIII of the Social Security Act to require prescription drug plan sponsors under the Medicare program to establish drug management programs for at-risk beneficiaries.

USA115th CongressHR-5675| House 
| Updated: 6/12/2018
This bill requires Medicare prescription drug plan (PDP) sponsors, for plan years beginning on or after January 1, 2021, to establish drug management programs for at-risk beneficiaries. Current law authorizes, but does not require, PDP sponsors to establish such programs.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 3, 2018
Introduced in House
May 3, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 9, 2018
Committee Consideration and Mark-up Session Held.
May 9, 2018
Ordered to be Reported by Voice Vote.
May 16, 2018
Referred to the Subcommittee on Health.
Jun 12, 2018
Placed on the Union Calendar, Calendar No. 577.
Jun 12, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-743, Part I.
Jun 12, 2018
Committee on Ways and Means discharged.
  • May 3, 2018
    Introduced in House


  • May 3, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 9, 2018
    Committee Consideration and Mark-up Session Held.


  • May 9, 2018
    Ordered to be Reported by Voice Vote.


  • May 16, 2018
    Referred to the Subcommittee on Health.


  • June 12, 2018
    Placed on the Union Calendar, Calendar No. 577.


  • June 12, 2018
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-743, Part I.


  • June 12, 2018
    Committee on Ways and Means discharged.
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (6)
Ben Ray Luján (Democratic)Marsha Blackburn (Republican)Greg Walden (Republican)Peter J. Roskam (Republican)Sander M. Levin (Democratic)Bill Posey (Republican)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • HR 115-5773: PASS Act of 2018
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug, alcohol, tobacco useMedicarePrescription drugs